[Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative].
Schulman
S
S
D000906:Antibodies / Q000032:analysis*; D001323:Autoantibodies; D005167:Factor VII / Q000008:administration & dosage*; D005169:Factor VIII / Q000276:immunology*; D006470:Hemorrhage / Q000276:immunology / Q000517:prevention & control; D006801:Humans
D000906:Antibodies; D001323:Autoantibodies; D005167:Factor VII; D005169:Factor VIII
Eliminering av antikroppar mot koagulationsfaktor VIII: Faktor VIIa mest lovande behandlingsalternativet.